PROGRESSION-FREE SURVIVAL IS A ROBUST SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Cabibbo, Giuseppe [1 ]
Celsa, Ciro [2 ,3 ]
Enea, Marco [2 ]
Battaglia, Salvatore [2 ]
Rizzo, Giacomo [2 ]
Busacca, Anita [2 ]
Matranga, Domenica [2 ]
Attanasio, Massimo [2 ]
Reig, Maria [4 ]
Craxi, Antonio [5 ]
Camma, Calogero [3 ]
机构：
[1] Univ Palermo, Dipartimento Biomed Med & Interne Specialist Di B, Sez Gastroenterol & Epatol, Palermo, Italy
[2] Univ Palermo, Palermo, Italy
[3] Univ Palermo, Sect Gastroenterol & Hepatol, Dipartimento Promoz Salute Materno Infantile Med, Palermo, Italy
[4] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc BCLC Grp, Liver Unit,Idibaps,Ciberehd, Barcelona, Spain
[5] Univ Palermo, Dibimis, Gastroenterolgy & Liver Unit, Palermo, Italy
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1068
引用
收藏
页码：649A / 649A
页数：1
相关论文
共 50 条
  • [21] Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    NEURO-ONCOLOGY, 2014, 16 (05) : 696 - 706
  • [22] Progression-free survival as a surrogate for overall survival in advanced cancer.
    Gillies, Eric
    Holdai, Veera
    Cowall, David Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] APPLICATION OF PROGRESSION-FREE SURVIVAL AS SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN NICE REVIEWS OF ADVANCED BREAST CANCER DRUGS
    Zou, D.
    Sun, A.
    Musci, R.
    Milev, S.
    VALUE IN HEALTH, 2022, 25 (01) : S183 - S184
  • [24] Progression-Free Survival as a Surrogate Marker of Overall Survival Is It the Good Question?
    Escudier, Bernard
    CANCER, 2011, 117 (12) : 2586 - 2587
  • [25] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [26] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [27] Progression-free survival as a surrogate endpoint in advanced breast cancer
    Miksad, Rebecca A.
    Zietemann, Vera
    Gothe, Raffaella
    Schwarzer, Ruth
    Conrads-Frank, Annette
    Schnell-Inderst, Petra
    Stollenwerk, Bjoern
    Siebert, Uwe
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 371 - 383
  • [28] Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms
    Imaoka, Hiroshi
    Sasaki, Mitsuhito
    Takahashi, Hideaki
    Hashimoto, Yusuke
    Ohno, Izumi
    Mitsunaga, Shuichi
    Watanabe, Kazuo
    Umemoto, Kumiko
    Kimura, Gen
    Suzuki, Yuko
    Ikeda, Masafumi
    ENDOCRINE-RELATED CANCER, 2017, 24 (09) : 475 - 483
  • [29] Radiotherapy with targeted and immunotherapy improved overall survival and progression-free survival for hepatocellular carcinoma with portal vein tumor thrombosis
    Ma, Jianing
    Zhang, Haifeng
    Zheng, Ruipeng
    Wang, Shudong
    Ding, Lijuan
    ONCOLOGIST, 2024,
  • [30] Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors
    Michiels, Stefan
    Saad, Everardo D.
    Buyse, Marc
    DRUGS, 2017, 77 (07) : 713 - 719
12345